Pfizer plans $350M China biotech plant

June 28, 2016 | U.S. drug-making giant Pfizer plans to invest roughly $350 to develop a biotechnology center in China, increasing the company's footprint in the world's second-largest pharmaceutical market, the firm said Monday. USA TODAY